Nov 7 (Reuters) - Cellmid Ltd (CDY) :
- EUROPEAN PATENT OFFICE ISSUES INTENTION TO GRANT FOR MIDKINE N-DOMAIN ANTIBODY PATENT
- PATENT COVERING LYRAMID'S ANTIBODY RECOGNIZING N-DOMAIN OF MIDKINE GRANTED IN USA
- HAS RECENTLY FILED TWO NEW PROVISIONAL PATENT APPLICATIONS FOR LYRAMID'S N-DOMAIN ANTIBODIES